“Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer” has been added to your cart. View cart

Article: The spectrum hypothesis and the technical revolution in radiotherapy at the origin of a major paradigm shift

€2.42

SKU: product-article-11145 Category: General

Description
Reviews (0)

Description

The spectrum hypothesis and the technical revolution in radiotherapy at the origin of a major paradigm shift

Reviews

There are no reviews yet.

Be the first to review “Article: The spectrum hypothesis and the technical revolution in radiotherapy at the origin of a major paradigm shift”

Top

Article: The spectrum hypothesis and the technical revolution in radiotherapy at the origin of a major paradigm shift

Description

Reviews

Related products

Article: Highlights in respiratory oncology

Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer

Article: Highlights in gynaecological cancers

Article: Highlights in squamous cell carcinoma of the head and neck